{"id":4703,"date":"2025-09-17T02:51:30","date_gmt":"2025-09-17T07:51:30","guid":{"rendered":"https:\/\/www.bocsci.com\/blog\/?p=4703"},"modified":"2025-09-17T02:53:24","modified_gmt":"2025-09-17T07:53:24","slug":"aptamer-aso-chimera-precision-delivery-of-therapeutic-oligonucleotides-for-targeted-gene-silencing","status":"publish","type":"post","link":"https:\/\/www.bocsci.com\/blog\/aptamer-aso-chimera-precision-delivery-of-therapeutic-oligonucleotides-for-targeted-gene-silencing\/","title":{"rendered":"<strong>Aptamer-ASO Chimera: Precision Delivery of Therapeutic Oligonucleotides for Targeted Gene Silencing<\/strong>"},"content":{"rendered":"\n<h2><strong>Technology Overview<\/strong><strong><\/strong><\/h2>\n\n\n\n<p>Aptamer-ASO chimeras are innovative bifunctional oligonucleotide therapeutics that combine the high-affinity targeting of aptamers with the gene-silencing capabilities of <a href=\"https:\/\/www.bocsci.com\/antisense-oligonucleotides-7393.html\">antisense oligonucleotides (ASOs)<\/a>&nbsp;[1]. This hybrid design enables precise delivery of ASOs to specific cells or tissues, enhancing therapeutic efficacy while minimizing off-target effects.<\/p>\n\n\n\n<p>By leveraging aptamers\u2019 ability to bind cell-surface biomarkers (e.g., receptors, proteins), the chimera selectively internalizes into target cells, where the ASO moiety modulates gene expression\u2014either by degrading mRNA, blocking translation, or altering splicing [2]. This approach is particularly valuable for treating cancers, viral infections, and inflammatory diseases.<\/p>\n\n\n\n<h2><strong>Key Advantages<\/strong><strong>&nbsp;of Aptamer-ASO Chimeras<\/strong><strong><\/strong><\/h2>\n\n\n\n<ul>\n<li>Targeted Delivery: Aptamers direct ASOs to diseased cells, reducing systemic toxicity [3].<\/li>\n\n\n\n<li>Dual Functionality: Simultaneous target recognition (aptamer) and gene regulation (ASO) [1].<\/li>\n\n\n\n<li>Enhanced Cellular Uptake: Engineered aptamers improve intracellular delivery efficiency [4].<\/li>\n\n\n\n<li>Modular Design: Customizable for diverse targets (e.g., SARS-CoV-2, PD-L1, hematologic markers) [5].<\/li>\n<\/ul>\n\n\n\n<h2><strong>Applications<\/strong><strong>&nbsp;in Precision Medicine<\/strong><strong><\/strong><\/h2>\n\n\n\n<p>1.Antiviral Therapy: Targeting SARS-CoV-2<\/p>\n\n\n\n<p>A circular aptamer-ASO chimera suppressed SARS-CoV-2 replication and inflammation by targeting viral RNA and host factors [1].<\/p>\n\n\n\n<p>2. Cancer Immunotherapy<\/p>\n\n\n\n<p>PD-L1-targeting aptamer-ASO chimeras blocked immune checkpoint signals and downregulated oncogenes, demonstrating dual anti-tumor effects [4].<\/p>\n\n\n\n<p>3.Hematologic Disorders<\/p>\n\n\n\n<p>Aptamer-ASO chimeras delivered therapeutics to malignant blood cells with high specificity [5].<\/p>\n\n\n\n<h2><strong>Design &amp; Optimization Strategies<\/strong><strong><\/strong><\/h2>\n\n\n\n<ul>\n<li>Aptamer Selection: Cell-internalizing aptamers (identified via SELEX) ensure efficient ASO delivery [3].<\/li>\n\n\n\n<li>Linker Chemistry: Stable linkages (e.g., phosphodiester, circularized backbones) enhance chimera stability in vivo [1].<\/li>\n\n\n\n<li>Base Modifications: Chemical tweaks (2\u2019-F, 2\u2019-OMe) improve nuclease resistance and binding affinity [2].<\/li>\n<\/ul>\n\n\n\n<h2><strong>Future Directions in Aptamer-ASO Therapeutics<\/strong><strong><\/strong><\/h2>\n\n\n\n<p>Advances in aptamer-ASO chimeras are expanding RNA therapeutics into precision medicine, with ongoing research focusing on:<\/p>\n\n\n\n<ul>\n<li>Multivalent targeting for complex diseases [4].<\/li>\n\n\n\n<li>Combination therapies (e.g., with siRNA or CRISPR) [2].<\/li>\n\n\n\n<li>Clinical translation for unmet needs [5].<\/li>\n<\/ul>\n\n\n\n<h2><strong>Our Aptamer-ASO Development Services<\/strong><strong><\/strong><\/h2>\n\n\n\n<p>At BOC Sciences, we specialize in custom Aptamer-ASO design and optimization to accelerate your therapeutic development pipeline.<\/p>\n\n\n\n<p>Our services include:<\/p>\n\n\n\n<ul>\n<li>Rapid aptamer discovery and selection from our proprietary library.<\/li>\n\n\n\n<li>Tailored ASO chemical modification for enhanced stability and potency.<\/li>\n\n\n\n<li>Scalable production and GMP-grade manufacturing.<\/li>\n\n\n\n<li>Preclinical validation support to fast-track your project toward regulatory approval.<\/li>\n<\/ul>\n\n\n\n<h2><strong>Ready to Advance Your Targeted RNA Therapeutics?<\/strong><strong><\/strong><\/h2>\n\n\n\n<p>Contact our expert team to explore how our Aptamer-ASO Chimera solutions can deliver your therapeutic payload with precision, efficiency, and reduced toxicity.<\/p>\n\n\n\n<p><a href=\"https:\/\/www.bocsci.com\/contactus.html\">Get a Free Consultation Today<\/a><\/p>\n\n\n\n<h2><strong>Our XDC Services<\/strong><strong><\/strong><\/h2>\n\n\n\n<p><a href=\"https:\/\/www.bocsci.com\/antibody-drug-conjugates-services.html\">Antibody-Drug Conjugates<\/a><\/p>\n\n\n\n<p><a href=\"https:\/\/www.bocsci.com\/antibody-oligonucleotide-conjugates.html\">Antibody-Oligonucleotide Conjugates<\/a><\/p>\n\n\n\n<p><a href=\"https:\/\/www.bocsci.com\/peptide-drug-conjugates.html\">Peptide-Drug Conjugates<\/a><\/p>\n\n\n\n<p><a href=\"https:\/\/www.bocsci.com\/small-molecule-drug-conjugates.html\">Small Molecule-Drug Conjugates<\/a><\/p>\n\n\n\n<p><a href=\"https:\/\/www.bocsci.com\/peptide-oligonucleotide-conjugates.html\">Peptide-Oligonucleotide Conjugates<\/a><\/p>\n\n\n\n<p><a href=\"https:\/\/www.bocsci.com\/services\/natural-products-active-molecules-conjugates.html\">Natural Products-Active Molecules Conjugates<\/a><\/p>\n\n\n\n<p><strong>References<\/strong><strong><\/strong><\/p>\n\n\n\n<ol type=\"1\">\n<li>Efficient Targeted Delivery of Bifunctional Circular Aptamer-ASO Chimera to Suppress the SARS-CoV-2 Proliferation and Inflammation \u2013 Small (2023) DOI: 10.1002\/smll.202207066<\/li>\n\n\n\n<li>Using aptamers for targeted delivery of RNA therapies \u2013 Molecular Therapy (2025) DOI: 10.1016\/j.ymthe.2025.02.047<\/li>\n\n\n\n<li>Base-modified aptamers obtained by cell-internalization SELEX facilitate cellular uptake of an antisense oligonucleotide \u2013 Molecular Therapy &#8211; Nucleic Acids (2020) DOI: 10.1016\/j.omtn.2020.11.016<\/li>\n\n\n\n<li>Anti-tumor effect of PD-L1-targeting antagonistic aptamer-ASO delivery system with dual inhibitory function in immunotherapy \u2013 Cell Chemical Biology (2023) DOI: 10.1016\/j.chembiol.2023.10.010<\/li>\n\n\n\n<li>Aptamers and Antisense Oligonucleotides for Diagnosis and Treatment of Hematological Diseases \u2013 International Journal of Molecular Sciences (2020) DOI: 10.3390\/ijms21093252<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>Technology Overview Aptamer-ASO chimeras are innovative bifunctional oligonucleotide therapeutics that combine the high-affinity targeting of aptamers with the gene-silencing capabilities of antisense oligonucleotides (ASOs)&nbsp;[1]. This hybrid design enables precise delivery [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/www.bocsci.com\/blog\/wp-json\/wp\/v2\/posts\/4703"}],"collection":[{"href":"https:\/\/www.bocsci.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bocsci.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bocsci.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bocsci.com\/blog\/wp-json\/wp\/v2\/comments?post=4703"}],"version-history":[{"count":3,"href":"https:\/\/www.bocsci.com\/blog\/wp-json\/wp\/v2\/posts\/4703\/revisions"}],"predecessor-version":[{"id":4708,"href":"https:\/\/www.bocsci.com\/blog\/wp-json\/wp\/v2\/posts\/4703\/revisions\/4708"}],"wp:attachment":[{"href":"https:\/\/www.bocsci.com\/blog\/wp-json\/wp\/v2\/media?parent=4703"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bocsci.com\/blog\/wp-json\/wp\/v2\/categories?post=4703"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bocsci.com\/blog\/wp-json\/wp\/v2\/tags?post=4703"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}